Documents
Application Sponsors
ANDA 074542 | BEXIMCO PHARMS USA | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | TABLET;ORAL | 5MG | 0 | GLIPIZIDE | GLIPIZIDE |
002 | TABLET;ORAL | 10MG | 0 | GLIPIZIDE | GLIPIZIDE |
FDA Submissions
Submissions Property Types
CDER Filings
BEXIMCO PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 74542
[companyName] => BEXIMCO PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"GLIPIZIDE","activeIngredients":"GLIPIZIDE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"GLIPIZIDE","activeIngredients":"GLIPIZIDE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"GLIPIZIDE","submission":"GLIPIZIDE","actionType":"5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"GLIPIZIDE","submission":"GLIPIZIDE","actionType":"10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)